• FAQs
  • Glossary
Close

FAQs

Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

See all FAQs

Close

Glossary

Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial

See full Glossary

Key MHRA Resources

UK MHPRA Logo

Guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) on Advanced Therapy Medicinal Products (ATMPs):

Read More
MHRA logo

MHRA Innovative Licensing and Access Pathway

MHRA's ILAP provides enhanced regulatory and expert support for the  development of innovative medicines.

Read more

  

Back to: Key Pathway Resources

External links

Back to top
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts